S

Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250

Watchlist Manager
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Watchlist
Price: 156 300 KRW 1.49% Market Closed
Market Cap: 3.7T KRW

Intrinsic Value

The intrinsic value of one Sam Chun Dang Pharm Co Ltd stock under the Base Case scenario is 6 910.86 KRW. Compared to the current market price of 156 300 KRW, Sam Chun Dang Pharm Co Ltd is Overvalued by 96%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
6 910.86 KRW
Overvaluation 96%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
Sam Chun Dang Pharm Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Sam Chun Dang Pharm Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Sam Chun Dang Pharm Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
KR
Pharmaceuticals
Market Cap
3.6T KRW
IPO
Oct 4, 2000
KR
Pharmaceuticals
Market Cap
3.6T KRW
IPO
Oct 4, 2000
Price
â‚©false
EPS
â‚©false
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Sam Chun Dang Pharm Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Sam Chun Dang Pharm Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sam Chun Dang Pharm Co Ltd

Current Assets 242.5B
Cash & Short-Term Investments 134.9B
Receivables 61.4B
Other Current Assets 46.2B
Non-Current Assets 277.2B
Long-Term Investments 31.2B
PP&E 103.6B
Intangibles 122.2B
Other Non-Current Assets 20.3B
Efficiency

Free Cash Flow Analysis
Sam Chun Dang Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sam Chun Dang Pharm Co Ltd

Revenue
210.9B KRW
Cost of Revenue
-111.3B KRW
Gross Profit
99.7B KRW
Operating Expenses
-97B KRW
Operating Income
2.6B KRW
Other Expenses
-13.6B KRW
Net Income
-10.9B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Sam Chun Dang Pharm Co Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
ROE is Increasing
39/100
Profitability
Score

Sam Chun Dang Pharm Co Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Sam Chun Dang Pharm Co Ltd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

91/100
Solvency
Score

Sam Chun Dang Pharm Co Ltd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Sam Chun Dang Pharm Co Ltd

There are no price targets for Sam Chun Dang Pharm Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Sam Chun Dang Pharm Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Sam Chun Dang Pharm Co Ltd stock?

The intrinsic value of one Sam Chun Dang Pharm Co Ltd stock under the Base Case scenario is 6 910.86 KRW.

Is Sam Chun Dang Pharm Co Ltd stock undervalued or overvalued?

Compared to the current market price of 156 300 KRW, Sam Chun Dang Pharm Co Ltd is Overvalued by 96%.

Back to Top